Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.19%750.1M | 6.90%1.8B | 4.48%817M | -4.41%1.69B | -0.09%781.96M | 10.45%1.76B | 10.58%782.65M | 5.18%1.6B | -4.48%707.8M | -4.68%1.52B |
| Operating income | -8.19%750.1M | 6.90%1.8B | 4.48%817M | -4.41%1.69B | -0.09%781.96M | 10.45%1.76B | 10.58%782.65M | 5.18%1.6B | -4.48%707.8M | -4.68%1.52B |
| Cost of sales | 9.59%-544.46M | -8.96%-1.29B | -10.95%-602.19M | 9.11%-1.18B | 9.45%-542.76M | -14.39%-1.3B | -22.76%-599.42M | -12.97%-1.14B | 0.38%-488.3M | 4.42%-1.01B |
| Operating expenses | 9.59%-544.46M | -8.96%-1.29B | -10.95%-602.19M | 9.11%-1.18B | 9.45%-542.76M | -14.39%-1.3B | -22.76%-599.42M | -12.97%-1.14B | 0.38%-488.3M | 4.42%-1.01B |
| Gross profit | -4.27%205.64M | 2.06%513.23M | -10.19%214.81M | 8.84%502.88M | 30.55%239.2M | 0.68%462.04M | -16.53%183.23M | -10.19%458.92M | -12.51%219.5M | -5.17%510.99M |
| Selling expenses | -11.92%-111.07M | -14.37%-242.48M | -1.93%-99.23M | 6.11%-212.01M | 14.04%-97.36M | -4.37%-225.8M | -19.71%-113.26M | 3.00%-216.35M | 5.58%-94.61M | -1.83%-223.05M |
| Administrative expenses | 1.30%-53.28M | -8.93%-111.38M | -18.14%-53.98M | -16.71%-102.24M | -5.92%-45.69M | -11.81%-87.61M | -7.45%-43.14M | -2.56%-78.35M | -2.55%-40.15M | -0.73%-76.4M |
| Impairment and provision | 113.45%854K | 26.44%-33.2M | 37.66%-6.35M | -108.17%-45.14M | -80.13%-10.19M | 38.63%-21.68M | 62.67%-5.66M | -4,209.02%-35.33M | -46.03%-15.15M | -116.30%-820K |
| -Other impairment is provision | 113.45%854K | 26.44%-33.2M | 37.66%-6.35M | -108.17%-45.14M | -80.13%-10.19M | 38.63%-21.68M | 62.67%-5.66M | -4,209.02%-35.33M | -46.03%-15.15M | -116.30%-820K |
| Special items of operating profit | -32.35%-13.63M | 3.52%-18.99M | -120.90%-10.3M | -47.77%-19.69M | 21.41%-4.66M | -124.96%-13.32M | -109.38%-5.93M | 414.77%53.36M | 994.47%63.22M | 78.16%-16.95M |
| Operating profit | -36.54%28.53M | -13.43%107.19M | -44.71%44.95M | 8.96%123.81M | 433.30%81.3M | -37.65%113.63M | -88.52%15.25M | -5.95%182.25M | 41.17%132.81M | 13.06%193.77M |
| Financing cost | 38.12%-11.32M | 1.78%-28.63M | -8.46%-18.29M | 6.31%-29.15M | 8.39%-16.87M | -0.46%-31.12M | -53.46%-18.41M | -39.31%-30.97M | 8.65%-12M | -10.90%-22.23M |
| Share of profits of associates | -4.62%-543K | -12.31%-1.16M | 34.39%-519K | 84.68%-1.03M | 61.69%-791K | -42.57%-6.74M | -69.12%-2.07M | -147.43%-4.73M | -160.34%-1.22M | 24.65%-1.91M |
| Share of profit from joint venture company | ---- | ---- | ---- | -317.33%-3.46M | -395.48%-3.07M | 123.85%1.59M | 115.15%1.04M | -1,294.57%-6.68M | -76,188.89%-6.87M | 66.27%-479K |
| Earning before tax | -36.24%16.67M | -14.16%77.4M | -56.84%26.14M | 16.54%90.17M | 1,545.26%60.57M | -44.68%77.37M | -103.72%-4.19M | -17.31%139.87M | 40.09%112.73M | 14.76%169.15M |
| Tax | 27.41%-7.45M | -0.26%-29.11M | 23.12%-10.26M | -91.71%-29.04M | -402.81%-13.35M | 52.02%-15.15M | 140.54%4.41M | -32.13%-31.56M | 18.34%-10.87M | 38.52%-23.89M |
| After-tax profit from continuing operations | -41.95%9.22M | -21.01%48.29M | -66.37%15.88M | -1.76%61.13M | 21,763.89%47.23M | -42.55%62.22M | -99.79%216K | -25.44%108.31M | 51.68%101.86M | 33.84%145.27M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---22.94M | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | -41.95%9.22M | -21.01%48.29M | -34.60%15.88M | -1.76%61.13M | 11,141.67%24.28M | -42.55%62.22M | -99.79%216K | -25.44%108.31M | 51.68%101.86M | 33.84%145.27M |
| Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---4.52M | ---- | ---- | ---- | ---- | ---- |
| Minority profit | 54.29%-2.6M | -121.52%-6.18M | -25.84%-5.68M | -16.17%-2.79M | -299.73%-4.52M | 66.31%-2.4M | 52.50%-1.13M | -374.38%-7.12M | -327.44%-2.38M | 348.42%2.6M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | --51.74M | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---22.94M | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -45.20%11.82M | -14.80%54.46M | -25.12%21.56M | -1.09%63.92M | 2,039.60%28.8M | -44.01%64.62M | -98.71%1.35M | -19.09%115.43M | 57.67%104.24M | 30.19%142.67M |
| Basic earnings per share | -45.19%0.0285 | -14.81%0.1312 | -25.07%0.052 | -1.09%0.154 | 2,068.75%0.0694 | -44.01%0.1557 | -98.73%0.0032 | -19.11%0.2781 | 57.69%0.2512 | 30.18%0.3438 |
| Diluted earnings per share | -19.11%0.2781 | 57.69%0.2512 | 30.18%0.3438 | |||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.